top
Advanced radiotherapy for prostate cancer to cut sessions from 20 to five
Key takeaways
- Senior doctors said the technique – called SABR (stereotactic ablative radiotherapy) - would target the disease more effectively than standard radiotherapy and help reduce side-effects.
- The treatment is already offered to some patients with other types of cancer, including lung and brain.
- This is the first time it will be offered to low- and intermediate-risk prostate cancer patients outside of trials.
Why this matters: a developing story that could shape the day's news cycle.
Nick Triggle Health correspondent Getty Images Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they need from 20 to just five.
Senior doctors said the technique – called SABR (stereotactic ablative radiotherapy) - would target the disease more effectively than standard radiotherapy and help reduce side-effects.
The treatment is already offered to some patients with other types of cancer, including lung and brain.
Article preview — originally published by BBC News. Full story at the source.
Read full story on BBC News →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from BBC News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop